Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Research ArticleResearch

Determination of the Acceptable Ambient Light Exposure during Drug Product Manufacturing for Long-Term Stability of Monoclonal Antibodies

Lin M. Luis, Yuzhe Hu, Camellia Zamiri and Alavattam Sreedhara
PDA Journal of Pharmaceutical Science and Technology July 2018, 72 (4) 393-403; DOI: https://doi.org/10.5731/pdajpst.2018.008581
Lin M. Luis
Late Stage Pharmaceutical Development, Genentech Inc., a Member of the Roche Group, South San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuzhe Hu
Late Stage Pharmaceutical Development, Genentech Inc., a Member of the Roche Group, South San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Camellia Zamiri
Late Stage Pharmaceutical Development, Genentech Inc., a Member of the Roche Group, South San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alavattam Sreedhara
Late Stage Pharmaceutical Development, Genentech Inc., a Member of the Roche Group, South San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: alavattam.sreedhara@gene.com
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 72 no. 4 393-403
DOI 
https://doi.org/10.5731/pdajpst.2018.008581
PubMed 
29853610

Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Published online August 9, 2018.

Article Versions

  • previous version (May 31, 2018 - 12:56).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© PDA, Inc. 2018

Author Information

  1. Lin M. Luis,
  2. Yuzhe Hu,
  3. Camellia Zamiri and
  4. Alavattam Sreedhara*
  1. Late Stage Pharmaceutical Development, Genentech Inc., a Member of the Roche Group, South San Francisco, CA, USA
  1. ↵* Corresponding Author: Late Stage Pharmaceutical Development, Genentech Inc., a Member of the Roche Group, 1 DNA Way, South San Francisco, CA 94080, USA. Telephone: 650-467-8488; e-mail: alavattam.sreedhara{at}gene.com
View Full Text

Cited By...

  • 19 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Physicochemical Stability of Monoclonal Antibodies: A Review
    Yoann Le Basle, Philip Chennell, Nicolas Tokhadze, Alain Astier, Valérie Sautou
    Journal of Pharmaceutical Sciences 2020 109 1
  • Science and art of protein formulation development
    Wei Wang, Satoshi Ohtake
    International Journal of Pharmaceutics 2019 568
  • Photo-Degradation of Therapeutic Proteins: Mechanistic Aspects
    Christian Schöneich
    Pharmaceutical Research 2020 37 3
  • Near UV and Visible Light Induce Iron-Dependent Photodegradation Reactions in Pharmaceutical Buffers: Mechanistic and Product Studies
    Natalia Subelzu, Christian Schöneich
    Molecular Pharmaceutics 2020 17 11
  • Probing the Tryptophan Environment in Therapeutic Proteins: Implications for Higher Order Structure on Tryptophan Oxidation
    Gregory V. Barnett, Gurusamy Balakrishnan, Naresh Chennamsetty, Laurel Hoffman, Jacob Bongers, Li Tao, Yunping Huang, Thomas Slaney, Tapan K. Das, Anthony Leone, Sambit R. Kar
    Journal of Pharmaceutical Sciences 2019 108 6
  • Stress Factors in Protein Drug Product Manufacturing and Their Impact on Product Quality
    Tapan K. Das, Alavattam Sreedhara, James D. Colandene, Danny K. Chou, Vasco Filipe, Christoph Grapentin, Jim Searles, Twinkle R. Christian, Linda O. Narhi, Wim Jiskoot
    Journal of Pharmaceutical Sciences 2022 111 4
  • Roadmap for Drug Product Development and Manufacturing of Biologics
    Krishnan Sampathkumar, Bruce A. Kerwin
    Journal of Pharmaceutical Sciences 2024 113 2
  • Light-Induced Histidine Adducts to an IgG1 Molecule Via Oxidized Histidine Residue and the Potential Impact of Polysorbate-20 Concentration
    Ming Lei, Cynthia Quan, John. Y. Wang, Yung-Hsiang Kao, Christian Schöneich
    Pharmaceutical Research 2021 38 3
  • Pharmaceutical Excipients Enhance Iron-Dependent Photo-Degradation in Pharmaceutical Buffers by near UV and Visible Light: Tyrosine Modification by Reactions of the Antioxidant Methionine in Citrate Buffer
    Natalia Subelzu, Christian Schöneich
    Pharmaceutical Research 2021 38 5
  • Primary Processes of Free Radical Formation in Pharmaceutical Formulations of Therapeutic Proteins
    Christian Schöneich
    Biomolecules 2023 13 7
  • Effect of light source and UVA quotient on monoclonal antibody stability during ambient light exposure studies
    Haresh T. More, Dilbir S. Bindra, Alexandra Zumba, Kaimeng Zhou, Thiago Carvalho, Rao Mantri
    European Journal of Pharmaceutics and Biopharmaceutics 2023 185
  • Near UV Photodegradation Mechanisms of Amino Acid Excipients: Formation of the Carbon Dioxide Radical Anion from Aspartate and Fe(III)
    Yilue Zhang, Yaqi Wu, Christian Schöneich
    Molecular Pharmaceutics 2024 21 3
  • Stability of Protein Pharmaceuticals: Recent Advances
    Mark Cornell Manning, Ryan E. Holcomb, Robert W. Payne, Joshua M. Stillahn, Brian D. Connolly, Derrick S. Katayama, Hongcheng Liu, James E. Matsuura, Brian M. Murphy, Charles S. Henry, Daan J. A. Crommelin
    Pharmaceutical Research 2024 41 7
  • Physical Instabilities of Therapeutic Monoclonal Antibodies: A Critical Review
    Arpit Arun K. Bana, Priti Mehta, Khushboo Ashok Kumar Ramnani
    Current Drug Discovery Technologies 2022 19 6
  • Visible Light Degradation of a Monoclonal Antibody in a High-Concentration Formulation: Characterization of a Tryptophan-Derived Chromophoric Photo-product by Comparison to Photo-degradation of N-Acetyl-l-tryptophan Amide
    Indira Prajapati, Nicholas R. Larson, Sureshkumar Choudhary, Cavan Kalonia, Suzanne Hudak, Reza Esfandiary, C. Russell Middaugh, Christian Schöneich
    Molecular Pharmaceutics 2021 18 9
  • Protein photodegradation in the visible range? Insights into protein photooxidation with respect to protein concentration
    Elena Hipper, Florian Lehmann, Wolfgang Kaiser, Göran Hübner, Julia Buske, Michaela Blech, Dariush Hinderberger, Patrick Garidel
    International Journal of Pharmaceutics: X 2023 5
  • Near UV Light Photo-Degradation of Lactate and Related α-Hydroxycarboxylates in the Presence of Fe(III): Formation of Carbon Dioxide Radical Anion
    Yilue Zhang, David S. Richards, Christian Schöneich
    Journal of Pharmaceutical Sciences 2024 113 9
  • Near UV and Visible Light Photodegradation in Solid Formulations: Generation of Carbon Dioxide Radical Anions from Citrate Buffer and Fe(III)
    Maribel Espinoza Ballesteros, Christian Schöneich
    Molecular Pharmaceutics 2024 21 9
  • The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
    John Geigert
    2019
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 72 (4)
PDA Journal of Pharmaceutical Science and Technology
Vol. 72, Issue 4
July/August 2018
  • Table of Contents
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Determination of the Acceptable Ambient Light Exposure during Drug Product Manufacturing for Long-Term Stability of Monoclonal Antibodies
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Determination of the Acceptable Ambient Light Exposure during Drug Product Manufacturing for Long-Term Stability of Monoclonal Antibodies
Lin M. Luis, Yuzhe Hu, Camellia Zamiri, Alavattam Sreedhara
PDA Journal of Pharmaceutical Science and Technology Jul 2018, 72 (4) 393-403; DOI: 10.5731/pdajpst.2018.008581

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Determination of the Acceptable Ambient Light Exposure during Drug Product Manufacturing for Long-Term Stability of Monoclonal Antibodies
Lin M. Luis, Yuzhe Hu, Camellia Zamiri, Alavattam Sreedhara
PDA Journal of Pharmaceutical Science and Technology Jul 2018, 72 (4) 393-403; DOI: 10.5731/pdajpst.2018.008581
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials
    • Methods
    • Results and Discussion
    • Conclusions
    • Conflict of Interest Declaration
    • Acknowledgments
    • Reference
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Quantitative and Qualitative Evaluation of Microorganism Profile Identified in Bioburden Analysis in a Biopharmaceutical Facility in Brazil: Criteria for Classification and Management of Results
  • Evaluation of Extreme Depyrogenation Conditions on the Surface Hydrolytic Resistance of Glass Containers for Pharmaceutical Use
  • A Holistic Approach for Filling Volume Variability Evaluation and Control with Statistical Tool
Show more Research

Similar Articles

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire